DJ Novavax Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ sank 0.69% to $8.64 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.98% to 19,764.89 and the Dow Jones Industrial Average rising 0.16% to 42,906.95.
The stock's fall snapped a two-day winning streak.
Novavax Inc. closed $15.22 below its 52-week high ($23.86), which the company achieved on June 6th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.55% to $145.27, Pfizer Inc. $(PFE)$ rose 1.33% to $26.71, and Merck & Co. Inc. $(MRK)$ rose 1.35% to $99.37.
Trading volume (2.1 M) remained 3.2 million below its 50-day average volume of 5.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 23, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 23, 2024 17:36 ET (22:36 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。